SynthesisOncotarget2016

Is angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy protective against prostate cancer?

Yeqing Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.